Daniela Criscuolo
Overview
Explore the profile of Daniela Criscuolo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
213
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Avolio R, Agliarulo I, Criscuolo D, Sarnataro D, Auriemma M, De Lella S, et al.
Genome Res
. 2023 Jul;
33(8):1242-1257.
PMID: 37487647
A complex interplay between mRNA translation and cellular respiration has been recently unveiled, but its regulation in humans is poorly characterized in either health or disease. Cancer cells radically reshape...
2.
Avolio R, Agliarulo I, Criscuolo D, Sarnataro D, Auriemma M, Pennacchio S, et al.
bioRxiv
. 2023 Jan;
PMID: 36712063
A complex interplay between mRNA translation and cellular respiration has been recently unveiled, but its regulation in humans is poorly characterized in either health or disease. Cancer cells radically reshape...
3.
Matassa D, Criscuolo D, Avolio R, Agliarulo I, Sarnataro D, Pacelli C, et al.
Cancer Cell Int
. 2022 Dec;
22(1):402.
PMID: 36510251
Background: Metabolic reprogramming is an important issue in tumor biology. A recently-identified actor in this regard is the molecular chaperone TRAP1, that is considered an oncogene in several cancers for...
4.
Criscuolo D, Morra F, Celetti A
Explor Target Antitumor Ther
. 2022 Nov;
3(5):570-581.
PMID: 36338517
Solute carrier family 7 member 11 (SLC7A11; also known as xCT), a key component of the cystine/glutamate antiporter, is essential for the maintenance of cellular redox status and the regulation...
5.
Criscuolo D, Avolio R, Parri M, Romano S, Chiarugi P, Matassa D, et al.
Antioxidants (Basel)
. 2022 Aug;
11(8).
PMID: 36009263
High-grade serous ovarian cancer (HGSOC) is the most common and aggressive OC histotype. Although initially sensitive to standard platinum-based chemotherapy, most HGSOC patients relapse and become chemoresistant. We have previously...
6.
Criscuolo D, Avolio R, Matassa D, Esposito F
Front Oncol
. 2021 Dec;
11:797265.
PMID: 34888254
Extensive metabolic remodeling is a fundamental feature of cancer cells. Although early reports attributed such remodeling to a loss of mitochondrial functions, it is now clear that mitochondria play central...
7.
Borriello G, Russo V, Paradiso R, Riccardi M, Criscuolo D, Verde G, et al.
Biomolecules
. 2020 May;
10(5).
PMID: 32438765
The protein MucR from Brucella abortus has been described as a transcriptional regulator of many virulence genes. It is a member of the Ros/MucR family comprising proteins that control the...
8.
Criscuolo D, Avolio R, Calice G, Laezza C, Paladino S, Navarra G, et al.
Cells
. 2020 Apr;
9(4).
PMID: 32235572
Despite initial chemotherapy response, ovarian cancer is the deadliest gynecologic cancer, due to frequent relapse and onset of drug resistance. To date, there is no affordable diagnostic/prognostic biomarker for early...
9.
Avolio R, Matassa D, Criscuolo D, Landriscina M, Esposito F
Biomolecules
. 2020 Jan;
10(1).
PMID: 31947673
Metabolic reprogramming, carried out by cancer cells to rapidly adapt to stress such as hypoxia and limited nutrient conditions, is an emerging concepts in tumor biology, and is now recognized...
10.
Criscuolo D, Morra F, Giannella R, Cerrato A, Celetti A
Int J Mol Sci
. 2019 Jun;
20(12).
PMID: 31242618
One of the most common malignancies in men is prostate cancer, for which androgen deprivation is the standard therapy. However, prostate cancer cells become insensitive to anti-androgen treatment and proceed...